ΠΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ 2'-ΡΠΎΡΡΠΎΠ΄ΠΈΡΡΡΠ΅ΡΠ°Π·Ρ Π² ΠΊΡΠ»ΡΡΡΡΠ΅ ΠΊΠ»Π΅ΡΠΎΠΊ NIH 3Π’3
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
Π Π°Π½Π΅Π΅ Π±ΡΠ»ΠΎ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ 2*.Π±'-ΠΎΠ»ΠΈΠ³ΠΎΠ¨ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΡΠ΅Ρ Ρ ΡΠΠ . ΡΠ΅ΡΠ΅Π· ΡΠΎΡΡΠΎΠ΄ΠΈΡΡΡΠ΅ΡΠ°Π·Ρ. ΡΠΠΠ ΠΏΠΎΡΠ»Π΅Π΄Π½ΡΡ Π°ΠΊΡΠΈΠ²ΠΈΡΡΠ΅ΡΡΡ 2,5,-ΠΎΠ»ΠΈ-Π³ΠΎ (Π) ΠΈ ΡΠ΅ΠΌ ΡΠ°ΠΌΡΠΌ ΡΠ½ΠΈΠΆΠ°Π΅Ρ ΡΡΠΎΠ²Π΅Π½Ρ ΡΠΠΠ . Π¦Π΅Π»ΡΡ Π½Π°ΡΠ΅ΠΉ ΡΠ°Π±ΠΎΡΡ Π±ΡΠ»ΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈΡΡ, ΠΏΠΎΠ΄Π²Π΅ΡΠΆΠ΅Π½Π° Π»ΠΈ 2'-ΡΠΎΡΡΠΎΠ΄ΠΈΡΡΡΠ΅ΡΠ°Π·Π° ΡΠΠΠ -Π·Π°Π²ΠΈΡΠΈΠΌΠΎΠΉ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΠΈ, Π΅ΡΠ»ΠΈ ΠΏΠΎΠ΄Π²Π΅ΡΠΆΠ΅Π½Π°, ΠΈΠ·ΡΡΠΈΡΡ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ ΡΡΠΎΠΉ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ. Π ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΎΠ±ΡΠ΅ΠΊΡΠ° ΠΌΡ Π²ΡΠ±ΡΠ°Π»ΠΈ Π»ΠΈΠ½ΠΈΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠ½ Π·ΡΠ·, Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ ΠΊΠΎΡΠΎΡΠΎΠΉ Ρ ΠΎΡΠΎΡΠΎ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΡΠΈΠ²Π΅Π½Π½ΠΈΠΊΠΎΠ² ΠΠ., ΠΡΠ»Π°ΡΠ³ΠΈΠ½Π° Π’. Π., ΠΡΠ»ΡΠ΅Π² H.H., Π‘Π΅Π²Π΅ΡΠΈΠ½ Π. Π‘. Π‘Π²ΠΎΠΉΡΡΠ²Π° ΠΊΠ°ΡΠ°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΠ±ΡΠ΅Π΄ΠΈΠ½ΠΈΡΡ ΡΠΠΠ -Π·Π°Π²ΠΈΡΠΈΠΌΠΎΠΉ ΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΊΠΈΠ½Π°Π·Ρ ΠΈΠ· Π³ΡΡΠ΄Π½ΠΎΠΉ ΠΌΡΡΡΡ Π³ΠΎΠ»ΡΠ±Ρ. ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ, 1979, 44, 771−780.
- ΠΡΠ»ΡΠ΅Π² H.H., Π’ΡΠ½ΠΈΡΠΊΠ°Ρ Π. Π., ΠΠ°ΡΠ°Π½ΠΎΠ²Π° Π. Π., ΠΠ΅ΡΡΠ΅ΡΠΎΠ²Π° Π. Π., ΠΡΡΡΡΠ·Π°Π΅Π² Π. Π., Π‘Π΅Π²Π΅ΡΠΈΠ½ Π.Π‘, ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΡΡΡΠΊΡΡΡΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΡΠ΅Π½ΡΡΠ° ΠΊΠ°ΡΠ°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΠ±ΡΠ΅Π΄ΠΈΠ½ΠΈΡΡ Π³ΠΈΡΡΠΎΠ½ΠΊΠΈΠ½Π°Π·Ρ. ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ, Ρ. 41, Ρ. I24I-I249.
- ΠΡΠ»ΡΠ΅Π² H.H., Π’ΡΠ½ΠΈΡΠΊΠ°Ρ Π. Π., ΠΠ΅ΡΡΠ΅ΡΠΎΠ²Π° Π. Π., ΠΠ°Π·ΡΡΠΎΠ²Π° Π. Π., ΠΡΡΡΡΠ·Π°Π΅Π² Π. Π., Π‘Π΅Π²Π΅ΡΠΈΠ½ Π. Π‘. ΠΠ·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ 8-Π·Π°ΠΌΠ΅ΡΠ΅Π½Π½ΡΡ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΡ ΠΈ ΡΡΠΈΡΠΎΠ² Π°Π΄Π΅Π½ΠΎΠ·ΠΈΠ½-3 *:5'-ΡΠΈΠΊΠ»ΠΎΡΠΎΡΡΠ°ΡΠ° Ρ ΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΊΠΈΠ½Π°-Π·ΠΎΠΉ ΠΌΠΎΠ·Π³Π° ΡΠ²ΠΈΠ½ΡΠΈ. ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ, 1977, Ρ. 42, Ρ. 2071−2079.
- ΠΠΏΠΈΡΠ°Π½ΠΎΠ²Π° Π.Π. ΠΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΌ ΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠΈΡΡΡΡΠΈΡ ΠΈ ΠΏΠΎΠΊΠΎΡΡΠΈΡ ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ. -Π¦ΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡ, 1979, Ρ. 21, Ρ. 1379−1396.
- ΠΠΏΠΈΡΠ°Π½ΠΎΠ²Π° Π.Π., Π’Π΅ΡΡΠΊΠΈΡ Π. Π. ΠΠ΅ΡΠΈΠΎΠ΄Ρ ΠΏΠΎΠΊΠΎΡ ΠΈ Π°ΠΊΡΠΈΠ²Π½ΠΎΠΉ ΠΏΡΠΎΠ»ΠΈ- -ΡΠ΅ΡΠ°ΡΠΈΠΈ Π² ΠΆΠΈΠ·Π½Π΅Π½Π½ΠΎΠΌ ΡΠΈΠΊΠ»Π΅ ΠΊΠ»Π΅ΡΠΊΠΈ. ΠΡΡΠ½. ΠΎΠ±Ρ. Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ, 1968, Ρ. 29, Ρ. 392−402Β¦
- ΠΠΏΠΈΡΠ°Π½ΠΎΠ²Π° Π. Π", Π’Π΅ΡΡΠΊΠΈΡ Π. Π., ΠΠΎΠ»ΡΠ½ΠΎΠ²ΡΠΊΠΈΠΉ Π. Π. ΠΠΎΠΊΠΎΡΡΠΈΠ΅ΡΡ ΠΊΠ»Π΅ΡΠΊΠΈ. Π.: ΠΠ°ΡΠΊΠ°, 1983, 176 Ρ.
- ΠΡΠΊΠ΅Ρ A.B., Π’ΡΠ½ΠΈΡΠΊΠ°Ρ Π. Π., Π‘Π΅Π²Π΅ΡΠΈΠ½ Π. Π‘. Π Π΅Π³ΡΠ»ΡΡΠΈΡ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΊΠ»Π΅ΡΠΊΠΈ ΡΠΈΡΡΠ΅ΠΌΠΎΠΉ Π²ΡΠΎΡΠΈΡΠ½ΡΡ ΠΌΠ΅ΡΡΠ΅Π½Π΄ΠΆΠ΅ΡΠΎΠ²: ΡΠΠΠ , 2', 5'-ΠΎΠ»ΠΈΠ³ΠΎΠ°Π΄Π΅Π½ΠΈΠ»Π°ΡΠ° ΠΈ ΠΊΠ°Π»ΡΡΠΈΡ. Π£ΡΠΏΠ΅Ρ ΠΈ Π±ΠΈΠΎΠ». Ρ ΠΈΠΌΠΈΠΈ, 1984, Π² ΠΏΠ΅ΡΠ°ΡΠΈ.
- ΠΠ°ΡΡΠ°ΡΠ΅Π²Π° Π.Π., ΠΡΠΊΠ΅Ρ A.B., Π’ΡΡΠΏΠ°Π΅Π² Π. Π’. Π’ΡΠ½ΠΈΡΠΊΠ°Ρ Π.Π., Π‘Π΅Π²Π΅ΡΠΈΠ½ Π. Π‘., ΠΠ°ΡΠΈΠ°Π½ΠΈ Π. Π. ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ 2'-ΡΠΎΡΡΠΎ-Π΄ΠΈΡΡΡΠ΅ΡΠ°Π·Ρ Π² ΠΊΡΠ»ΡΡΡΡΠ΅ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠ½ Π·ΡΠ·. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡ. Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ, 1984, Ρ. 18, Π² ΠΏΠ΅ΡΠ°ΡΠΈ.
- ΠΠΎΡΠ΅ΡΠΊΠΎΠ² Π‘.Π., ΠΠ°Π³ΠΈΡΠΎΠ² Π. Π., ΠΠ°Π±ΠΈΠ±ΠΎΠ² Π. Π., Π‘Π΅Π²Π΅ΡΠΈΠ½ Π. Π‘. ΠΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ ΡΠΠΠ -Π·Π°Π²ΠΈΡΠΈΠΌΠΎΠΉ ΡΡΠΎΡΠ΅ΠΈΠ½ΠΊΠΈΠ½Π°Π·Ρ. Π¨. ΠΡΠ΅Π΄ΠΏΠΎΠ»Π°Π³Π°Π΅ΠΌΠ°ΡΡΠΎΠ»Ρ ΠΊΠ°ΡΠ±ΠΎΠΊΡΠΈΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΡΠ΅ΡΠΌΠ΅Π½ΡΠ°. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡ. Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ, 1984, Ρ. 18, Ρ. 704−711.
- ΠΠΎΡΠ΅ΡΠΊΠΎΠ² Π‘.Π., ΠΠ°Π±ΠΈΠ±ΠΎΠ² Π. Π., ΠΠ°ΡΡΡΡ Π. Π., Π¨ΠΈΠ±Π½Π΅Π² Π. Π., Π‘Π΅Π²Π΅ΡΠΈΠ½ Π. Π‘. ΠΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ ΡΠΠΠ -Π·Π°Π²ΠΈΡΠΈΠΌΠΎΠΉ ΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΊΠΈΠ½Π°Π·Ρ. 1Π£. ΠΠ·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ ΠΊΠ°ΡΠ°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΠ±ΡΠ΅Π΄ΠΈΠ½ΠΈΡΡ ΡΠΎ ΡΡΡΡΠΊΡΡΡΠ½ΡΠΌΠΈ Π°Π½Π°Π»ΠΎΠ³Π°ΠΌΠΈ Π³ΠΈΡΡΠΎΠ½Π° ΠΠ. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡ. Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ, 1984, Ρ.18, Ρ. 901−906.
- ΠΠ΅ΡΡΠ΅ΡΠΎΠ²Π° Π.Π., ΠΠ°ΡΠ±Π°ΡΠΎΠ² Π‘.Π€, ΠΡΠΈΠΏΠ΄ΠΆΠ°Π½ΠΎΠ² Π., ΠΠ±Π΄ΡΠ·ΡΠ°ΡΠΈΠΌΠΎΠ² A.A., Π‘Π΅Π²Π΅ΡΠΈΠ½ Π. Π‘. Π’ΡΠ°Π½ΡΠ»ΠΎΠΊΠ°ΡΠΈΡ Π² ΡΡΡΡ ΠΈ Π²Π»ΠΈΡΠ½ΠΈΠ΅ ΡΠΠΠ -Π·Π°Π²ΠΈ-ΡΠΈΠΌΠΎΠΉ ΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΊΠΈΠ½Π°Π·Ρ Π½Π° ΠΏΡΠΎΡΠ΅ΡΡ ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΈΠΈ. ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ, 1980, Ρ. 45, Ρ. 979−991.'
- Π’Π΅ΡΡΠΊΠΈΡ Π.Π., ΠΠΎΡΠΈΠΌΠΎΠ²ΡΠΊΠ°Ρ Π. Π. Π‘ΠΈΠ½ΡΠ΅Π· ΠΠΠ ΠΈ ΡΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΡ ΠΏΡΠΈ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΌ ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΊΠΈΡΠ°ΠΉΡΠΊΠΎΠ³ΠΎ Ρ ΠΎΠΌΡΡΠΊΠ°. -Π¦ΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡ, 1971, Ρ. 13, Ρ. 1379−1387.
- Π’ΡΠ½ΠΈΡΠΊΠ°Ρ Π.Π., ΠΡΠΊΠ΅Ρ A.B., ΠΠΎΡΠ΅ΡΠΊΠΎΠ²Π° Π. Π., Π‘Π΅Π²Π΅ΡΠΈΠ½ Π. Π‘. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΡΠΎΡΠ΅ΡΡΠ° Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ ΡΠΎΡΡΠΎΠ΄ΠΈΡΡΡΠ΅ΡΠ°Π·Ρ ΡΠΈΠΊΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π΄Π΅Π½ΠΎΠ·ΠΈΠ½-3*, 5'-ΠΌΠΎΠ½ΠΎΡΠΎΡΡΠ°ΡΠ° 2*, 5'-ΠΎΠ»ΠΈΠ³ΠΎΠ°Π΄Π΅Π½ΠΈΠ»Π°ΡΠΎΠΌ, ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ, 1983, Ρ. 48, Ρ. I72I-I725.
- Π’ΡΠ½ΠΈΡΠΊΠ°Ρ Π.Π., Π¦ΡΠΊΠΎΠ²ΡΠΊΠ° Π., ΠΠ°ΡΡΠ°ΡΠ΅Π²Π° Π. Π., ΠΡΠΊΠ΅Ρ A.B., Π‘Π΅Π²Π΅ΡΠΈΠ½ Π.Π‘, Π‘ΠΈΡΡΠ΅ΠΌΠ° ΡΠΠΠ -Π·Π°Π²ΠΈΡΠΈΠΌΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠΈΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΈ ΡΠ³Π»ΡΠ±Π»Π΅Π½ΠΈΠΈ ΠΊΠ»Π΅ΡΠΎΠΊ nih Π·ΡΠ· Π² ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ ΠΏΠΎΠΊΠΎΡ. ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ, 1984, Ρ. 49, Ρ, I0I9-I025.
- Π£Π»ΡΠΌΠ°ΡΠΎΠ² Π₯.Π., ΠΠ΅ΡΡΠ΅ΡΠΎΠ²Π° Π. Π., Π‘Π΅Π²Π΅ΡΠΈΠ½ Π. Π‘. ΠΠ²ΡΠΎΡΠΎΡΡΠΎΡΠΈΠ»ΠΈ-ΡΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΠΠ -Π·Π°Π²ΠΈΡΠΈΠΌΠΎΠΉ ΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΊΠΈΠ½Π°Π·Ρ ΠΈΠ· ΠΌΠΎΠ·Π³Π° ΡΠ²ΠΈΠ½ΡΠΈ, ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ, 1980, Ρ. 45, Ρ. 661−668.
- Π£Π»ΡΠΌΠ°ΡΠΎΠ² Π₯. Π, ΠΠ΅ΡΡΠ΅ΡΠΎΠ²Π° Π. Π., Π‘Π΅Π²Π΅ΡΠΈΠ½ Π. Π‘. ΡΠΠΠ -Π·Π°Π²ΠΈΡΠΈΠΌΠ°Ρ ΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΊΠΈΠ½Π°Π·Π° ΠΈΠ· ΠΌΠΎΠ·Π³Π° ΡΠ²ΠΈΠ½ΡΠΈ: ΡΡΠ±ΡΠ΅Π΄ΠΈΠ½ΠΈΡΠ½Π°Ρ ΡΡΡΡΠΊΡΡΡΠ°, ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ Π°Π²ΡΠΎΡΠΎΡΡΠΎΡΠΈΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈ Π΄ΠΈΡΡΠΎΡΠΈΠ°ΡΠΈΡ Π½Π° ΡΡΠ±ΡΠ΅Π΄ΠΈΠ½ΠΈΡΡ ΠΏΠΎΠ΄ Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ΠΌ ΡΠΠΠ . ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ, 1980, Ρ. 45, Ρ. 835−844.
- Abell G.W., Monahan Π’.Π. The role of adenosine 3*, 5'-cyclic monophosphate in the regulation of mammalian cell division.- J. Cell Biol., 1973, v. 59, P.54−9-558.
- Abelson H.T., Johnson L.F., Penman S., Green H. Changes in Π¨Π relation to growth of the fibroblast: II. The lifetimeof mENA, rBNA, and tKNA in resting and growing cells. Cell, 1974, v.1, p.161−164.
- Adhya S., Garges S. How cyclic AMP and its receptor protein act in Escherichia coli. Cell, 1982, v.29, p.287−289.
- Aitken A., Bilham Π’., Cohen P. Complete primary structure of protein phosphatase inhibitor-1 from rabbit skeletal muscle.- Eur. J. Biochem., 1982, v.126, p.235−246.
- Aitken A., Cohen P. Isolation and characterization of active fragments of protein phosphatase inhibitor-1 from rabbit skeletal muscle. EEBS Lett., 1982, v.147, p.54−58.
- Augenlicht L.H., Baserga K. Changes in the GQ state of WI-38 fibroblasts at different times after confluence. Exp. Cell Res., 1974, v.89, p.255−262.
- Baglioni C. Interferon-induced enzymatic activities and their role in the antiviral state. Cell, 1979, v.17, p.255−264.
- Baglioni C., Maroney P.A. Inhibition of double-stranded ribonucleic acid activated protein kinase and 2', 5*-oligo (adenylic acid) polymerase by ethidium bromide. Biochemistry, 1980, v.20, p.758−762.
- Baglioni C., Minks M.A., Maroney P.A. Interferon action may «be mediated by activation of a nuclease by pppA2'p5,A2'p5,A. Nature, 1978, v.273, p.684−687.
- Ball L.A. 2*, 5'-oligoadenylate synthetase. In: The Enzymes (Ed. P.D. Boyer), 1981, v.15, p.281−313.
- Ball L.A., White O.N. Oligonucleotide inhibitor of protein synthesis made in extracts of interferon-treated chick embryo cells: comparison with the mouse low molecular weight inhibitor. Broc. Natl. Acad. Sci. USA, 1979, v.75» p.1167−1171.
- Bandman E. Stabilization of mENA following serum-induction of quiescent 3T3cells. Mol. Biol. Rep., 1977, v.3, p.421−428.
- Beavo J.A., Bechtel P.J., Krebs E.G. Mechanisms of control for cAMP-dependent protein kinase from skeletal muscle. -Adv. Cycl. Nucl. Res., 1975, v.5, p.241−251.
- Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem., 1976, «^.72, p.248−254.
- Burchell A., Eoulkes J.G., Cohen P.T.W., Oondon G.D., Cohen P, Evidence for the involvement of protein phosphatase-1 in the regulation of metabolic processes other than glycogen metabolism. EEBS Lett., 1978, v.92, p.68−72.
- NAD+, ADP-ribose and adenosine (5')tetraphospho (5f)adenosine. -Eur. J. Biochem., 1982, v.122, p.601−608.
- Cohen P. Well established systems of enzyme regulation by reversible phosphorylation. In: Molecular aspects of cellular regulation. /Ed. Cohen P., Elsevier/North Holland, Biomedical Press, 1980, v.1| p.1−10.
- Cohen P. Protein phosphorylation and the co-ordinated control of intermedialy metabolism. Ins Molecular aspects of cellular regulation /Ed. Cohen P., Elsevier/ North Holland, Biochemical Press, 1980, v.1, p.255−268.
- Cho-Chung Y.S. Cyclic AMP and its receptor protein in tumor growth regulation in vivo. J. Cycl. Nucl. Res., 1980, v.6, p.163−177.
- Chu-Der O.M.I., Ortwerth B.J. Xys-tRNA^ and cell division. Changes in lys-tRNA during the growth of mouse L cells. -Exp. Cell Res., 1980, v.128, p.159−170.
- Clemens M.J., Williams B.R.G. Inhibitor of cell-free protein synthesis by pppA2, p5lA2"p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell, 1978, v.13, p.565−572.
- Collett M.S., Brugge J.S., Erikson R.L. Characterization of a normal avian cell protein related to the avian sarcomavirus transforming gene product. Cell, 1978″ v.15, p.1363−1369.
- Collett M.S., Erikson E., Purchio A.F., Brugge J.S., Eriskon R.L. A normal cell protein similar in structure and function to the avian sarcoma virus transforming gene product. -Proc. Natl. Acad. Sci. USA, 1979, v.76, p.3159−3163.
- Conlon-Hollingshead C., Orthwerth B.J. Lys-tRNA^ levels and cell division in mouse 3T3 cells. Exp. Cell Res., 1980, v.128, p.171−180.
- Cooper H.L. Studies of poly (A)-bearing RM in resting and growing human lymphocytes. In: Control of proliferation in animal cells. /Ed. by B. Clarkson, R.Baserga. Cold Spring Harbor Conferences on Cell Proliferation, 1974, v.1, p.769−783.
- Cooper H.L., Braverman R. Protein synthesis in resting and growth-stimulated human peripheral lymphocytes. Evidence for regulation by a-non-messenger RNA. Exp. Cell Res., 1980, v.127, p.351−359.
- Corbin J.D., Keely C.J., Park C.R. The distribution and dissociation of cyclic adenosine 3': 5'-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues.
- J. Biol. Chem., 1975, v.250, p.218−225.
- Corbin J.D., Rannels S.R., Flockart D.A., Robinson A.M., Atkins P.D. Cyclic nucleotide biiiding sites of protein kinases. Cold Spring Harbor Conferences on Cell Proliferation, 1981, v.8, p.45.
- Corbin J.D., Sugden P.H., West I»., Elockhart D.A., Lincoln T.M., McCarthy D. Studies on the properties and mode of action of the purified regulatory subunit of bovine heart cAMP-dependent protein kinase. J. Biol. Chem., 1978″ v.253, p.3997−4003.
- Costa E., Kurosava A., Gui&otti A. Activation and nuclear translocation of protein kinase daring transsynaptic induction of tyrosine 3-monooxygenase. Proc. Natl. Acad. Sci. USA, 1976, v.73″ p.1058−1062.
- Dougherty J.P., Samanta H., Farrell P.J., Lengyel P. Interferon, double-stranded BNA, and RNA degradation. J. Biol. Chem., 1981, v.255, p.3813−3816.
- Erlichman J., Sarkar D., Fleischer N., Rubin C.S. Identification of two subclasses cf type II cAMP-dependent protein kinases. J. Biol. Chem., 1980, v.255, p.8179−8184.
- Etienne-Smekens M., Vandenbussche P., Content J., Dumont J.E. (2,-5l)01igoadenylate in rat liver: modulation after partial hepatectomy. Proc. Natl. Acad. Sci. USA, 1983, v.80, p.4609−4613.
- Evans R.B., Morhenn V., Jones A.L., Tomkins G.M. Concomitant effects of insulin on surface membrane conformation and polysome profiles of serum-starved Balb/c3G?3 fibroblasts. J. Cell Biol., 1974, v.61, p.95−106.
- Farrell P.J., Sen G.C., Dubois M.F., Ratner L., SlatteryE., Lengyel P. Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded. RNA. Proc. Natl. Acad. Sci. USA, 1978, v.75, p.5893−5897.
- Fellows M., Nir U., Wallach D., Merlin G., Rubinstein M., Revel M. Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lympho-blastoid cells. Proc. Natl. Acad. Sci. USA, 1982, v.79,p.3082−3086.
- Ferbus D., Justensen J., Besancon F., Thang M.N. The 2"-5' oligoadenylate synthetase has a multifunctional 2'^'-nucleotidyl-transferase activity. Biochem. Biopbys. Res. Communs., 1981, v.100, p.84−7-856.
- Flockart D.A., Corbin J.D. Regulatory mechanisms in the control of protein kinases. Critical Reviews in Biochemistry, 1982, v.12, p.133−186.
- Floyd-Smith G., Slattery E., Lengyel P. Interferon action RNA cleavage pattern of a (2*-5')oligoadenylate-dependent endo-nuclease. Science, 1981, v.212, p.1030−1032.
- Floyd-Smith G., Xoshie 0., Lengyel P. Interferon action: co-valent linkage of (2"-5')pppApApA (32P)pGp to (2'-5″)(A)n-de-pendent ribonuclease in cell extracts by UV irradiation. -J. Biol. Chem., 1982, v.257, p.8584−8587.
- Foulkes J.G., Cohen P. The hormonal control of glicogen metabolism. Phosphorylation of protein phosphatase inhibitor-1in vivo in response to adrenaline. Eur. J. Biochem., 1979, v.97, p.251−256.
- Foulkes J.G., Cohen P. The regulation of glicogen metabolism. Purification and properties of protein phosphatase inhibitor-2from rabbit skeletal muscle, Eur. J. Biochem., 1980, v.105, p.195−203.
- Foulkes J.G., Jefferson L.S., Cohen P. The hormonal control of glicogen metabolism: dephosphorylation of protein phosphatase inhibitor-1 in vivo in response to insulin. FEBS Lett., 1980, v.112, p.21−24.
- Foulkes J.G., Strada S.J., Henderson P.J.F., Cohen P. A kinetic analysis of the effects of inhibitor-1 and inhibitor-2 on the activity of protein phosphatase-1. Eur. J. Biochem., 1983, v. 132, p.309−313.
- Friedman D.L. Role of cyclic nucleotides in cell growth and differentiation. Physiol. Res, 1976, v.56, p.652−708.
- Friedman D.L., Larner J. Studies on UDPG-oC-Glucan transglu-cosylase, III. Interconversion of two forms of muscle UDPG-«6 -Glucan transglucosylase by a phosphorylation-dephosphoryla-tion reaction sequence. Biochemistry, 193″ v.2, p.669−675″
- Friedman-Einat M., Revel M., Kimchi A. Initial characterization of a spontaneous interferon secreted during growth and differentiation of Friend erythroleukemia cells. Mol. Cell Biol., 1982, v.2, p.1472−1480.
- Gewert D.R., Moore G., Tilleray V.J., Clemens M.S. Inhibition of cell proliferation by interferon. 1. Effects on cell division and DNA synthesis in human lymphoblastoid (Daugi) cells. Eur. J. Biochem., 1984, v.139, p.§ 19−625.
- Gillen R.G., Nagyvary J, Some biochemical properties of alkyl phosphotriesters. Biochem. Biophys. Res. Communs., 1976, v. 68, p.836−840.
- Gunter G.R., Wang J. I»., Edelman G.M. The kinetics of cellular commitment during stimulation of lymphocytes by lectins.
- J. Cell Biol., 1974, v.62, p.366−377.
- Haddox M.K., Magun B.E., Russel D.H. Differential expression of type I and type II cyclic AMP-dependent protein kinases during cell cycle and cyclic AMP-induced growth arrest. -Proc. Natl. Acad. Sci. USA, 1980, v.77, p.3445−3449.
- Hathaway G.M., Traugh J.A. Cyclic nucleotide-independent protein kinases from rabbit reticulocytes. J.Biol. Chem., 1979″ v.254, p.762−768.
- Hovanessian A.G., Kerr I.M. The (2*-5″)oligoadenylate CpppA2"-5'A2'-5'A)synthetase and protein kinase (s) from interferon-treated cells. Eur. J. Biochem., 1978, v.93, p.515−526.
- Hovanessian A.G., Wood J.N. Anticellular and antiviral effects of pppA (2"p5"A)n. Virology, 1980, v.101, p.81−90.
- Howard A., Pelc S.R. Synthesis of desoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity, 1953, v.6, Suppl., p.261−273.
- Howard D.K., Hey J., Melvin W.T., Durham J.P. Changes in DNA and ENA synthesis and associated enzyme activities after the stimulation of serum-depleted BHK 21/C13 cells by the addition of serum. E2q?. Cell Res., 1974, v.86, p.31−42.
- Huang F.L., Glinsmann W.H. Separation and characterization of. two phosphorylase phosphatase inhibitors from rabbit skeletal muscle. Eur. J. Biochem., 1976, v.70, p.419−426.
- Ingebritsen T.S., Cohen P. The protein phosphatases involved in cellular regulation. 1. Classification and substrate specificities. Eur. J. Biochem., 1983, v.132, p.255−261.
- Ingebritsen T.S., Foulkes J.G., Cohen P. The protein phosphatases involved in cellular regulation. 2. Glicogen metabolism. Eur. J. Biochem., 1983, v, 132, p.263−274.
- Inoue M., Kishimoto A., Takaj Y., Nishizaka Y. Guanosine 31: 5'monophosphate-dependent protein kinase from silkworm: properties of a catalytic fragment obtained by limited proteolysis. J. Biol. Chem., 1976, v.251, p.4476−4478.
- Isaacs A. Interferon. Scientific American, 1961, v.204, p.51−57.
- Itkes A.V., Kochetkova M.N. Activation of phosphodiesterase of cyclic adenosine monophosphate by 2', 5'-oligoadenylate. -Biochem. Int., 1981, v.3, p.341−347.
- Itkes A.V., Turpaev K.T., Kartasheva O.N., Kafiani C.A., Severin E.S. Cyclic AMP-dependent regulation of activities of synthetase and phosphodiesterase of 2', 51-oligoadenylate in NIH 3T3 cells. Mol. Cell Biochemistry, 1984, v.58, pf165−171.
- Jaehning J.A., Stewart C.C., Boeder E.G. DNA-dependent RNA-polynerase levels during the response of human peripheral lymphocytes to phytohemagglutinin. Cell, 1975″ v.4, p.51−57.
- Johnson L.E., Abelson H.T., Green H., Penman S. Changes in RNA in relation to growth of the fibroblasts. 1. Amounts of mRNArRNA, and tRNA in resting and growing cells. Cell, 1974″ v.1, p. 95−100.
- Johnson L.F., Levis R., Abelson H.T., Green H., Penman S. Changes in MA in relation to growth of the fibroblast. 4. Alteration in the production and processing of mRNA and rBHA in resting and growing cells. J. Cell Biol., 1976, v.71″ p.933−938.
- Johnson L.F., Williams J.G., Abelson H.T. Changes in RNA in relation to growth, of the fibroblast. 3. Post-transcriptional regulation of mENA formation in resting and growing cells. Cell, 1975, v.4, p.69−75.
- Justesen J., Ferbus D., Thang M.N. 2β’, 51Oligoadenylate synthetase, an interferon induced enzymes direct assay methods for the products, 2,5,oligoadenylates and 21,5β’co-oligonuc-leotides. Nucl. Acids Res., 1980, v.8, p.3073−3085.
- Kerr I.M., Brown R.E. pppA2"p5,A2,p5lA: An inhibitor of protein synthesis synthesized with an enzyme fraction from interferon" treated cells. Proc. Natl. Acad. Sci. USA, 195*8, v. 75, p.256−260.
- Khatra B.S., Chiasson S.L., Shikama H., Exton J.H., Soderling T.R. Effect of epinephrine and insulin on the phosphorylation of phosphorylase phosphatase inhibitor-1 in perfused rat skeletal muscle. FEBS Lett., 1980, v.114, p.253−256.
- Kimchi A. Increased levels of interferon-induced (2,-5,)oli-goisoadenylate synthetase in mature T-lymphocytes and in differentiated Friend-erythroleukemic cells. J. Interferon Res., 1981, v.1, p.559−569.
- Kimchi A., Shulman L., Schmidt A., Chernajovsky Y., Fradin A., Revel M. Kinetics of the induction of three translation-regulatory enzymes by interferon. Eroc. Natl. Acad. Sci. USA, 1979″ v.76, p.3208−3212.
- Kimchi A., Shure H., Revel M. Anti-mitogenic function of in-terferon-induced (2,-5l)oligo (adenylate) and growth-related variations in enzymes that synthesize and degrade this oligonucleotide. Eur. J. Biochem., 1981, v.114, p.5−10.
- Knight M., Cayley P.J., Silverman R.H., Wreschner D.H.,
- Gilbert C.S., Brown R.E., Kerr I.M. Radioimmune, radiobind-ing and HPLC analysis of 2−5A and related oligonucleotides from intact cells. Nature, 1980, v.288, p.189−192.
- Kochetkov S.N., Bulargina T.V., Sashcheiiko L.P., Severin, E.S. Role of a histidine resiquejin the active site of cyclic AMP-dependent histone kinase. EBBS Lett., 1976, v.?1, p. 212−214.
- Kolodny G.M. Turnover of ribosomal RNA in mouse fibroblasts (3T3) in culture. Exp. Cell Res., 1975, v.91, p.101−106.
- Krebs E.G., Beavo J.A. Phosphorylation-dephosphorylation ofenzymes. Arm. Rev. Biochem., 1979, v.48, p.923−959.
- Krishnan I., Baglioni C. Elevated levels of (2'-5')oligo-adenylic acid polymerase activity in growth-arrested human lymphoblastbid iFamalva cells. Mol. Cell Biol., 1981, v.1, P.932−938.
- Laurent G.S., Yoshie 0., Floid-Smith G., Samanta H., Sehgal P.B., Lengyel P. Interferon action: two (2,-5') (A)n synthetases specified by distinct mBNAs in Ehrlich ascites tumor cells treated with interferon. Cell, 1983, v.33, p.95−102.
- Lebleu B., Sen G.C., Shaila S., Carbrer B., Lengyel P. Interferon, double-strabded HIT A, and protein phosphorylation. -- Proc. Natl. Acad. Sci. USA, 1976, v.73, p.3107−3111.
- Lengyel P. Mechanisms of interferon action: the (2'-5*) (A)n synthetase. ENase L pathway. — In: Interferon 3 / Ed. Gres-ser I., Acad, Press, Lond., 1981, p.78−99.
- Levis R., McReynolds L., Penman S. Coordinate regulation of protein synthesis and messenger RNA content during growth arrest of suspension Chinese hamster ovary cells. J. Cell Physiol., 1977, v.90, p.485−502.
- Lincoln T.M., Corbin J.D. Hypothesis: on the role of the cAMP and cGMP-dependent protein kinase in cell function. -J. Cycl. Nucl. Res., 1978, v.4, p.3.
- Lincoln G?.M., Flockhart D.A., Corbin J.D. Studies on thestructure and mechanism of activation of the cGMP-dependent protein kinase. J. Biol. Chem., 1978, v.253, p.6002−6009.
- Matsunrura S., TakecLa M. Phosphoprotein kinases from rat liver cytosol. Biochim. Biophys. Acta, 1972, v.289, p.237−241.
- Matsuo M., Chang L., Huang 0., Villar-Palasi C. Kinetic mechanism of skeletal muscle cyclic AMP-dependent protein kinase. HUBS Lett., 1978, v.87, p.77−79.
- Minks M.A., Benvin S., Maroney P.A., Baglioni 0. Synthesis of 2', 5'-oligo (A) in extracts of interferon-treated HeLa cells. J. Biol. Chem., 1979, v.254, p.5058−5064.
- Minks M.A., Benvin S., Marroney P.A., Baglioni C. Metabolic stability of 2'5foligo (A) and activity of 2'5'(A)-dependent endonuclease in extracts of interferon-treated and control HeLa cells. Nucleic Acids Hes., 1979, v.6, p.767−780.
- Minks M.A., West D.K., Benvin S., Baglioni C. Structural requirements of double-stranded SNA for the activation of2*, 5'-oligo (A) polymerase and protein kinase of interferons treated HeLa cells. J. Biol. Chem., 1979, v.254, p.10 180−10 183.
- Misumi Y., Nishio Y., Shiokawa K., Yamana K. RNA metabolism in primary cultures of Xenopus laevis kidney cells. III. Processing of rENA precursor in growing and resting cells. -Exp. Cell Res., 1978, v.114, p.239−245.
- Moens W., Vokaer A., Kram E. Cyclic AMP and cyclic GMP concentrations in serum- and density-restricted fibroblast cultures. Proc. Natl. Acad. Sci. USA, 1975, v.72, p.1063−1067.
- Neldolesi M.P., Friedman R.M., Kohn L.D. An interferon-induced increase in cyclic AMP levels preceds the establishment of the antiviral state. Biochem. Biopbys. Res. Commun., 1977, v.79, p.239−246.
- Nesterova M.V., Glukhov A.I., Severin E.S. Effect of the regulatory subunit of cAMP-dependent protein kinase on the genetic activity of eukaryotic cells. Mol, Cell Biochem., 1982, v.49, p.53−61.
- Hesterova M.V., Sashchenko L.P., Vasil’ev V.Yu., Severin E.S. A cyclic adenosine 3*, 5*-monophosphate-dependent his-tone kinase from pig brain. Purification and some properties of the enzyme. Biochim. Biophys. Acta, 1975, v.377, p.271−286.
- Nesterova M.V., Ul’masov Kh.A., Abdukarimov A.A., Aripdzanov A., Severin E.S. Nuclear translocation of cAMP-dependent protein kinase. Esq). Cell Res., 1981, v.132, p.367−373.
- Nicolini C.A., Linden W.A., Zietz S., Wu C.T. Identification of non-proliferating cells in melanoma B16 tumor. Nature, 1977, v.270, p.607−609.
- Nilsen T.W., Baglioni C. Mechanism for discrimination between viral and host mRNA in interferon-treated cells. -Proc. Natl. Acad. Sci. USA, 1979, v.76, p.2600−2604.
- Nilsen T.W., Weissman S.G., Baglioni C. Role of 2,5'-oligo (adenylic acid) polymerase in the degradation of ribonucleic acid linked to double-stranded ribonucleic acid by extracts of interferon-treated cells. Biochemistry, 1980, v.19,p.5574−5579.
- Nilsen-Hamilton M., Hamilton R.T. Fibroblast growth factor causes an early increase in phosphorylation of a membrane protein in quiescent 3T3 cells. Nature, 1979, v.279,p.444−446.
- N.iinmo G.A., Cohen P. The regulation of glicogen metabolism. Phosphorylation of inhibitor 1 from rabbit skeletal muscle, and its interaction with, protein phosphatases-III and II. -Eur. F. Biochem., 1978, v. b?, p. 353−365.
- Oakley B.H., Kirsch D.R., Morris N. R, A simplified ultrasensitive silver stain for detecting proteins in polyacry-lamide gels. Anal. Biochem., 1980, v.105, p.361−366.
- Otten J., Johnson G.S., Pastan I. Cyclic AMP levels in fibroblasts: relationship to growth rate and contact inhibitionof growth. J. Biol. Chem., 1972, v.247, p.7082−7087.
- Pardee A.B., Dubrow R., Hamlin E.K., Kletzien R.F. Animal cell cycle. Ann. Rev. Biochem., 1978, v.47, p.715−750.
- Pastan I., Johnson G.S., Anderson W.B. Role of cyclic nucleotides in growth control. Ann. Rev. Biochem., 1975> v.44, p.491−522.
- Pledger W.J., Gardner R.M., Epstein P.M. Cell cycle traverse and macromolecular synthesis in BHK fibroblasts as affected by insulin. Exp. Cell Res., 1979, v.118, p.389−394.
- Rannels S.R., Corbin J.D. Studies of functional domains of the regulatory subunit from cAMP-dependent protein kinase isozyme I. J. Cycl. Nucl. Res., 1980, v.6, p.201−215.
- Rappoport S., Arad G., Lapidot Y., Panet A. Activation of ribonuclease E by the two isomers (2'-5')oligoadenylate and C31−51)oligoadenylate. EEBS Lett., 1982, v.149, p.47−50.
- Reeves R., Jones A. Genomic transcriptional activity and the structure of chromatin. Nature, 1976^ v.260, p.495−500.
- Role of cyclic AMP in cell function /Greengard P., Gesta E. eds./ Raven Press, H.Y., 1970, v.3.
- Rosen O.M., Erlichman J. Reversible autophosphorylation ofa cyclic 31: 5'-AMP-dependent protein kinase from bovine cardiac muscle. J. Biol. Chem., 1975, v.250, p.7788−7794.
- Rosen O.M., Rubin C.S., Erlichman J. Properties of the cyclic AMP-dependent protein kinase from bovine and porcine heart. -In: Enz. Reg. /Weber G. e&.J, Pergamon Press, N.Y., 1975″ v.13, p.173−185.
- Rudland P. S., Jimenez de Asua L. Action of growth factors in the cell cycle. Biochim. Biophys. acta, 1979, v. 560, p. 91−133.
- Russel D.H. Ornithine decarboaylase may be a multifunctionalprotein. In: Adv. Enz. Reg. /Weber G. ed./, Pergamon Press, 1983, v.21, p.201−222.
- Sakawa Y., Nagata K., Ichikawa Y. Induction and function of 21^-oligoadenylate synthetase in differentiation of mouse myeloid leukemia cells. Exp. Cell Res., 1981, v.135″ p.191−197.
- Schmidt A., Cherna/ovsky Y., Shulman L., Federman P., Be-rissi H., Revel M. An interferon-induced phosphodiesterase degrading (2'-5')oligoisoadenylate and C-C-A terminus of tBNA. Proc. Natl. Acad. Sci. USA, 1979″ v.76, p.4788−4792
- Schmidt A., Zilberstein A., Shulman L., Eederman P., Beris-si H., Revel M. Interferon action: isolation of nuclease 3?, a translation inhibitor activated by interferon-induced (2'-5″)-oligoisoadenylate. EEBS Lett., 1978, v.95″ p.257−264.
- Sen G.O., Gupta S.L., Brown G.E., Lebleu B., Rebello M.A., Lengyel P. Interferon treatment of Ehrlich ascites cells: effects on exogenous mRNA translation and tRNA inactivation in the cell extract. J. Virol., 1976, v.17, p.191−203.
- Sen G. C, Taira H., Lengyel P. Interferon, double-stranded RNA, and protein phosphorylation. J. Biol. Chem., 1978, v.253, p.5915−5921.
- Sheppard H., Wiggan G. Analogs of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone as potent inhibitors of rat erythrocyte adenosine cyclic 31"5*-phosphate phosphodiesterase. Mol. Phyrmacol., 1971, v.7, p.111−120.
- Sheppard J.R. Restoration of contact-inhibited growth to transformed cells by dibutyryl adenosine 3' ^'-cyclic monophosphate. Proc. Natl. Acad. Sci. USA, 1981, v.68, p.1316−1320.
- Sheppard J.R. Differences in the cyclic adenosine 3,"5'"-monophosphate levels in normal and transformed cells. -Nature New Biol., 1972, v.236, p.14−16.
- Sheridan J.W., Bishop G.J., Simmons R.J. Biophysical and morphological correlates of kinetic change and death in a starved human melanoma cell line. J. Cell Sci., 1981, v.49, p.119−137.
- Shizuta Y., Beavo J.A., Bechtel P.J., Krebs E.G. Reversibility of cAMP-dependent protein kinase reactions. J. Biol.
- Ctaem., 1975, v.250, p.6891−6896.2+
- Shulman H., Greengard P. Ca -Dependent protein phosphorylation system in membranes from various tissues, and its activation by «calcium-dependent regulator». Proc. Natl. Acad. Sci. USA, 1978, v.75, p.5432−5436.
- Silverman R.H., Cayley P.J., Knight M., Gilbert C.S., Kerr I.M. Control of ppp (A2*p)nA system in HeLa cells. Effectsof interferon and virus infection. Eur. J. Biochem., 1982, v.124, p.131−138.
- Slattery E., Ghosh N., Samanta H., Lengyel P. Interferon, double-strahded RNA, and RNA degradation: activation of an endonuclease by (2,-5')An. Proc. Natl. Acad. Sci. USA, 1979, v.76, p.4778−4782.
- Spaggiare S., Wallach M.J., Tupper J.T. Potassium transport in normal and transformed mouse 33 cells. J. Cell Physiol., 1976, v.89, p.403−416.
- Stark G.R., Dower W.J., Schimke R.T., Brown R.E., Kerr I.M. 2−5A Synthetase: assay, distribution and variation with growth or hormone status. Nature, 1979, v.278, p.471−473.
- Todaro G.J., Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol., 1963, v.17, p, 299−313.
- Tovey M.G., Rochette-Egly C., Castagna M. Effect of interferon on concentrations of cyclic nucleotides in cultured cells. Proc. Natl. Acad. Sci. USA, 1979, v.76, p.3890−3893.
- Trakht i.n., Grozdova i.d., Vasil’ev V.Yu., Severin E.S. Evolutionary aspects of the «biological action of cyclic nucleotides. Biosystems, 1980, v.12, p.305−316.
- Vilcek S., Vrtiak O.J., Smrt J., Jurovcik M. Stability of (2'-5')oligo?iboadenylates in various sera. EEBS Lett., 1984, v.166, p.311−313.
- Walsh D.A., Krebs E.G., Protein kinases. The Enzymes, 1973, v.8, p.555−581.
- Walsh D.A., Perkins J.P., Krebs E.G. An adenosine 3', 5f-monophosphate-dependent protein kinase from rabbit skeletal muscle. J. Biol. Chem., 1968, v.243, p.3763−3765.
- Weber M.J. Ribosomal RNA turnover in contact inhibited cells. Nature New Biol., 1972, v.235, p.58−61.
- Weber W., Hilz H. Stoichiometry of cAMP binding and limited proteolysis of protein kinase regulatory subunits EI and RII. Biochem. Biophys. Res. Commun., 1979, v.90, p.1073−1081.
- Wehner J.M., Sheppard J.R., Malkinson A.M. Density-dependent phosphorylation of a specific protein in cultured cells. -Nature, 1977, v.266, p.842−844.
- Weber J.M., Stewart R.B. Cyclic AMP potentiation of interferon antiviral activity and effect of interferon on cellular cyclic AMP levels. J. Gen. Virol., 1975» v.28, p.363−372.
- Weissenbach J., Dirheimer G., Ealcoff R., Sanceau J., lal-coff E. Yeast tRNALeu (anticodon U-A-G) translates all six leucine codons in extracts from interferon treated cells. -EBBS Lett., 1977, v.82, p.71−76.
- Williams B.R.G., Golpher R.R., Kerr I.M. Activation of a nucleases by pppA2'p5'A2'p5fA in intact cells. EEBS Lett., 1979, v.105, p.47−52.
- Williams B.R.G., Golpher R.R., Brown R.E., Gilbert C.S., Kerr I.M. Natural occurrence of 2−5A in interferon-treated EMC virus-infected L cells. Nature, 1979i v.282, p.582−586.
- Williams B.R.G., Kerr I.M. Inhibition of protein synthesis by 2'-5f linked adenine oligonucleotides in intact cells. -Nature, 1978, v.276, p.88−90.
- Williams B.R.G., Kerr I.M., Gilbert C.S., White C.N., Ball L.A. Synthesis and breakdown of pppA2, p5,A2'p5,A and transient inhibition of protein synthesis in extracts from interferon-treated and control cells. Eur. J. Biochem., 1978, v. 92, p.455−462.
- Yang K., Samanta H., Dougherty J., Jayaram B., Broeze R., Lengyel P. Interferon, double-stranded RNA, and RNA degradation. Isolation and characterization of homogeneous human2'-5″)(A)n synthetase. J. Biol. Chem., 1981, v.256,p.9324−9328.
- Zeilig C.E., Johnson E.A., Friedman D.L., Sutherland E.W. Cyclic AMP concentrations in synchronized HeLa cells. -J. Cell Biol., 1972, v. 55. p.296a.
- Zilberstein A., Dubock B., Berissi H., Eevel M. Control of messenger ENA translocation by minor species of leucyl-transfer ENA in extracts from interferon-treated L cells. J. Mol. Biol., 1976, v.108, p.43−54.
- Zilberstein A., Kimchi A., Schmidt A., Eevel M. Isolation of two interferon-induced translational inhibitors: a protein kinase and oligo-isoadenylate synthetase. Proc. Natl. Acad. Sci. USA, 1978, v.75, p.4734−4738.
- ΠΠ½Π΅ Ρ ΠΎΡΠ΅ΡΡΡ ΠΏΠΎΠ±Π»Π°Π³ΠΎΠ΄Π°ΡΠΈΡΡ ΠΏΡΠΎΡΠ΅ΡΡΠΎΡΠ° ΠΠ²Π³Π΅Π½ΠΈΡ Π‘Π΅ΡΠ³Π΅Π΅Π²ΠΈΡΠ° Π‘Π΅Π²Π΅ΡΠΈΠ½Π°, ΠΊΠΎΡΠΎΡΡΠΉ Π²ΠΏΠ΅ΡΠ²ΡΠ΅ ΠΏΡΠΈΠ²Π»Π΅ΠΊ ΠΌΠΎΠ΅ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΊ ΡΡΠΎΠ»Ρ ΠΈΠ½ΡΠ΅ΡΠ΅ΡΠ½ΠΎΠΉ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ΅, Π·Π° ΠΏΠΎΡΡΠΎΡΠ½Π½ΠΎΠ΅ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΊ Π½Π°ΡΡΠΎΡΡΠ΅ΠΌΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΈ ΠΏΠ»ΠΎΠ΄ΠΎΡΠ²ΠΎΡΠ½ΠΎΠ΅ ΠΎΠ±ΡΡΠΆΠ΄Π΅Π½ΠΈΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ².